These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 26846302)

  • 1. Acute nephrotoxicity of aristolochic acid in vitro: metabolomics study for intracellular metabolic time-course changes.
    Liu X; Liu Y; Cheng M; Xiao H
    Biomarkers; 2016; 21(3):233-42. PubMed ID: 26846302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is aristolochic acid nephropathy a widespread problem in developing countries? A case study of Aristolochia indica L. in Bangladesh using an ethnobotanical-phytochemical approach.
    Michl J; Jennings HM; Kite GC; Ingrouille MJ; Simmonds MS; Heinrich M
    J Ethnopharmacol; 2013 Aug; 149(1):235-44. PubMed ID: 23806867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomics analysis of altered proteins in kidney of mice with aristolochic acid nephropathy using the fluorogenic derivatization-liquid chromatography-tandem mass spectrometry method.
    Lin CE; Chang WS; Lee JA; Chang TY; Huang YS; Hirasaki Y; Chen HS; Imai K; Chen SM
    Biomed Chromatogr; 2018 Mar; 32(3):. PubMed ID: 29088495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible role of mitochondrial injury in Caulis Aristolochia manshuriensis-induced chronic aristolochic acid nephropathy.
    Liu X; Wu J; Wang J; Fan J; Feng X; Yu X; Yang X
    Drug Chem Toxicol; 2017 Jan; 40(1):115-124. PubMed ID: 27250112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolomics insights into activated redox signaling and lipid metabolism dysfunction in chronic kidney disease progression.
    Chen H; Cao G; Chen DQ; Wang M; Vaziri ND; Zhang ZH; Mao JR; Bai X; Zhao YY
    Redox Biol; 2016 Dec; 10():168-178. PubMed ID: 27750081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LC-MS- and (1)H NMR-Based Metabolomic Analysis and in Vitro Toxicological Assessment of 43 Aristolochia Species.
    Michl J; Kite GC; Wanke S; Zierau O; Vollmer G; Neinhuis C; Simmonds MS; Heinrich M
    J Nat Prod; 2016 Jan; 79(1):30-7. PubMed ID: 26706944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary metabolomics and biomarkers of aristolochic acid nephrotoxicity by UPLC-QTOF/HDMS.
    Zhao YY; Tang DD; Chen H; Mao JR; Bai X; Cheng XH; Xiao XY
    Bioanalysis; 2015; 7(6):685-700. PubMed ID: 25871586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro effects of Panax ginseng in aristolochic acid-mediated renal tubulotoxicity: apoptosis versus regeneration.
    Bunel V; Antoine MH; Nortier J; Duez P; Stévigny C
    Planta Med; 2015 Mar; 81(5):363-72. PubMed ID: 25798640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary Time- or Dose-Dependent Metabolic Biomarkers of Aristolochic Acid-Induced Nephrotoxicity in Rats.
    Hu X; Shen J; Pu X; Zheng N; Deng Z; Zhang Z; Li H
    Toxicol Sci; 2017 Mar; 156(1):123-132. PubMed ID: 28115647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aristolochic acid nephropathy: epidemiology, clinical presentation, and treatment.
    Luciano RL; Perazella MA
    Drug Saf; 2015 Jan; 38(1):55-64. PubMed ID: 25446374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and nephrotoxicity of aristolochic acid in rabbits.
    Chen SM; Fan MY; Tseng CC; Ho Y; Hsu KY
    Toxicon; 2007 Aug; 50(2):180-8. PubMed ID: 17512963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma metabolic profiling analysis of nephrotoxicity induced by acyclovir using metabonomics coupled with multivariate data analysis.
    Zhang X; Li Y; Zhou H; Fan S; Zhang Z; Wang L; Zhang Y
    J Pharm Biomed Anal; 2014 Aug; 97():151-6. PubMed ID: 24863373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New aristolochic acid, aristololactam and renal cytotoxic constituents from the stem and leaves of Aristolochia contorta.
    Zhang CY; Wang X; Su T; Ma CM; Wen YJ; Shang MY; Li XM; Liu GX; Cai SQ
    Pharmazie; 2005 Oct; 60(10):785-8. PubMed ID: 16259129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two New Aristolochic Acid Analogues from the Roots of
    Ji HJ; Li JY; Wu SF; Wu WY; Yao CL; Yao S; Zhang JQ; Guo DA
    Molecules; 2020 Dec; 26(1):. PubMed ID: 33374869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early proximal tubule injury in experimental aristolochic acid nephropathy: functional and histological studies.
    Lebeau C; Debelle FD; Arlt VM; Pozdzik A; De Prez EG; Phillips DH; Deschodt-Lanckman MM; Vanherweghem JL; Nortier JL
    Nephrol Dial Transplant; 2005 Nov; 20(11):2321-32. PubMed ID: 16077141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal Protective Effects of 17β-Estradiol on Mice with Acute Aristolochic Acid Nephropathy.
    Shi M; Ma L; Zhou L; Fu P
    Molecules; 2016 Oct; 21(10):. PubMed ID: 27763560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognition of the toxicity of aristolochic acid.
    Zhang HM; Zhao XH; Sun ZH; Li GC; Liu GC; Sun LR; Hou JQ; Zhou W
    J Clin Pharm Ther; 2019 Apr; 44(2):157-162. PubMed ID: 30548302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aristolochic acid nephropathy: variation in presentation and prognosis.
    Yang L; Su T; Li XM; Wang X; Cai SQ; Meng LQ; Zou WZ; Wang HY
    Nephrol Dial Transplant; 2012 Jan; 27(1):292-8. PubMed ID: 21719716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The safety of Homnawakod herbal formula containing Aristolochia tagala Cham. in Wistar rats.
    Tripatara P; Onlamul W; Booranasubkajorn S; Wattanarangsan J; Huabprasert S; Lumlerdkij N; Akarasereenont P; Laohapand T
    BMC Complement Altern Med; 2012 Oct; 12():170. PubMed ID: 23031193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current status of injury caused by Chinese herbal medicine and its counter measure].
    Dai XW; Rao XR; Li S
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2001 Jan; 21(1):58-61. PubMed ID: 12577382
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.